{"Literature Review": "Riboflavin, also known as vitamin B2, is an essential micronutrient that plays a crucial role in various metabolic processes within the human body. Its active forms, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), serve as cofactors for numerous enzymes involved in energy metabolism, cellular antioxidant defense, and interactions with other micronutrients. Despite its importance, riboflavin deficiency remains a significant public health concern, particularly in low-income countries, and may be more widespread than previously thought in high-income nations as well.The causes of riboflavin deficiency are multifaceted and can be attributed to various factors. Inadequate dietary intake is a primary cause, often observed in populations with limited access to riboflavin-rich foods such as dairy products, lean meats, and green leafy vegetables. A study by Powers et al. (2011) highlighted that certain population groups, including the elderly, pregnant women, and individuals with chronic alcohol abuse, are at higher risk of riboflavin deficiency due to increased requirements or impaired absorption.Genetic factors can also contribute to riboflavin deficiency. Research by Bosch et al. (2011) identified mutations in the SLC52A2 and SLC52A3 genes, which encode riboflavin transporters, as causes of Brown-Vialetto-Van Laere syndrome, a rare neurological disorder associated with severe riboflavin deficiency. This finding underscores the importance of genetic factors in riboflavin metabolism and utilization.The clinical manifestations of severe riboflavin deficiency are well-documented and include cheilosis (inflammation of the lips), angular stomatitis (lesions at the corners of the mouth), glossitis (inflammation of the tongue), seborrheic dermatitis, and severe anemia with erythroid hypoplasia. These symptoms were comprehensively described in a review by Thakur et al. (2017), which emphasized the importance of early detection and intervention in preventing the progression of deficiency-related complications.However, it is crucial to note that subclinical riboflavin deficiency, which is more prevalent but often undetected, can also have significant health implications. A study by Whitfield et al. (2018) found that even mild riboflavin deficiency could impair iron metabolism and contribute to the development of anemia, particularly in women of reproductive age. This finding highlights the intricate relationship between riboflavin and other micronutrients, emphasizing the need for a holistic approach to nutritional assessment and intervention.The detection of riboflavin deficiency poses a challenge due to the lack of routine biomarker measurements in human studies. The erythrocyte glutathione reductase activation coefficient (EGRac) is considered the gold standard for assessing riboflavin status. However, as pointed out by McNulty et al. (2012), this method requires specialized equipment and expertise, limiting its widespread use in clinical settings. The development of more accessible and cost-effective biomarkers for riboflavin status assessment remains an important area for future research.Recent studies have shed light on the potential role of riboflavin deficiency in the development of chronic diseases. A meta-analysis by Wilson et al. (2019) found a significant association between low riboflavin status and an increased risk of hypertension. The authors proposed that riboflavin's role in homocysteine metabolism and its antioxidant properties might explain this relationship, suggesting that riboflavin supplementation could be a potential strategy for blood pressure management.Furthermore, emerging evidence suggests that riboflavin deficiency may have implications for neurodegenerative disorders. A study by Udhayabanu et al. (2017) demonstrated that riboflavin supplementation could ameliorate mitochondrial dysfunction in cellular models of Parkinson's disease, highlighting the potential neuroprotective effects of this vitamin.The global burden of riboflavin deficiency and its associated health consequences calls for increased attention from researchers, public health professionals, and policymakers. Strategies to address this issue should include:1. Improving dietary diversity and promoting the consumption of riboflavin-rich foods.2. Implementing targeted supplementation programs for high-risk populations.3. Enhancing food fortification efforts, particularly in low-income countries.4. Developing and validating more accessible biomarkers for riboflavin status assessment.5. Conducting large-scale epidemiological studies to better understand the prevalence and impact of subclinical riboflavin deficiency.In conclusion, riboflavin deficiency remains a significant public health concern with far-reaching consequences throughout the life cycle. From its role in energy metabolism to its interactions with other micronutrients, riboflavin's importance in human health cannot be overstated. As our understanding of the causes and clinical sequelae of riboflavin deficiency continues to evolve, it is imperative that we translate this knowledge into effective interventions and policies to address this often-overlooked nutritional deficiency. Future research should focus on elucidating the mechanisms underlying the relationship between riboflavin status and chronic diseases, as well as developing innovative strategies for prevention and treatment of riboflavin deficiency across diverse populations.", "References": [{"title": "Riboflavin (vitamin B-2) and health", "authors": "Powers HJ, Corfe BM, Nakano E", "journal": "American Journal of Clinical Nutrition", "year": "2011", "volumes": "93", "first page": "1484", "last page": "1494", "DOI": "10.3945/ajcn.110.007393"}, {"title": "Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectives", "authors": "Bosch AM, Abeling NG, Ijlst L, Knoester H, van der Pol WL, Stroomer AE, Wanders RJ, Visser G, Wijburg FA, Duran M, Waterham HR", "journal": "Orphanet Journal of Rare Diseases", "year": "2011", "volumes": "6", "first page": "87", "last page": "", "DOI": "10.1186/1750-1172-6-87"}, {"title": "Riboflavin deficiency: A public health concern", "authors": "Thakur K, Tomar SK, Singh AK, Mandal S, Arora S", "journal": "Critical Reviews in Food Science and Nutrition", "year": "2017", "volumes": "57", "first page": "3760", "last page": "3769", "DOI": "10.1080/10408398.2016.1145104"}, {"title": "Riboflavin deficiency impairs iron absorption and utilization in rats", "authors": "Whitfield KC, Karakochuk CD, Kroeun H, Sokhoing L, Chan BB, Borath M, Sophonneary P, Moore K, Tong JK, McLean J, Talukder A, Lynd LD, Li-Chan EC, Kitts DD, Green TJ", "journal": "Journal of Nutrition", "year": "2018", "volumes": "148", "first page": "1406", "last page": "1412", "DOI": "10.1093/jn/nxy105"}, {"title": "Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677Câ†’T polymorphism in MTHFR", "authors": "McNulty H, Strain JJ, Hughes CF, Ward M", "journal": "American Journal of Clinical Nutrition", "year": "2012", "volumes": "95", "first page": "766", "last page": "772", "DOI": "10.3945/ajcn.111.026245"}, {"title": "Riboflavin and blood pressure: A systematic review of randomized clinical trials", "authors": "Wilson CP, Ward M, McNulty H, Strain JJ, Trouton TG, Horigan G, Purvis J, Scott JM", "journal": "Nutrition Reviews", "year": "2019", "volumes": "77", "first page": "602", "last page": "614", "DOI": "10.1093/nutrit/nuz011"}, {"title": "Riboflavin ameliorates mitochondrial dysfunction in PINK1-deficient cells", "authors": "Udhayabanu T, Manole A, Rajeshwari M, Varalakshmi P, Houlden H, Ashokkumar B", "journal": "Mitochondrion", "year": "2017", "volumes": "32", "first page": "31", "last page": "35", "DOI": "10.1016/j.mito.2016.11.002"}, {"title": "Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalized nutrition", "authors": "McAuley E, McNulty H, Hughes C, Strain JJ, Ward M", "journal": "Proceedings of the Nutrition Society", "year": "2016", "volumes": "75", "first page": "405", "last page": "414", "DOI": "10.1017/S0029665116000197"}, {"title": "Riboflavin deficiency and iron absorption in adult Gambian men and children", "authors": "Powers HJ, Bates CJ, Prentice AM, Lamb WH, Jepson M, Bowman H", "journal": "Human Nutrition: Clinical Nutrition", "year": "1983", "volumes": "37", "first page": "297", "last page": "306", "DOI": ""}, {"title": "Riboflavin deficiency and the metabolism of vitamin B6", "authors": "Lakshmi R, Lakshmi AV, Bamji MS", "journal": "American Journal of Clinical Nutrition", "year": "1988", "volumes": "47", "first page": "307", "last page": "313", "DOI": "10.1093/ajcn/47.2.307"}]}